We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
-12.04%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$10.9B
AUM Growth
-$2.03B
Cap. Flow
-$121M
Cap. Flow %
-1.1%
Top 10 Hldgs %
91.49%
Holding
36
New
4
Increased
5
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$84.7M
2
XP icon
XP
XP
+$52.1M
3
ARCE
Arco Platform Limited Class A Common Shares
ARCE
+$21.1M
4
GTM
ZoomInfo Technologies
GTM
+$3.84M
5
RNG icon
RingCentral
RNG
+$3.8M

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$191M
2
DNA icon
Ginkgo Bioworks
DNA
+$101M

Sector Composition

Rank Sector Weight
1 Technology 46.5%
2 Healthcare 29.1%
3 Financials 13.91%
4 Industrials 4.65%
5 Consumer Staples 4.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESMT
1
DELISTED
EngageSmart, Inc.
ESMT
$2.07B 18.94%
97,209,436
– –
DLO icon
2
dLocal
DLO
$4.28B
$1.79B 16.38%
57,310,939
– –
OSH
3
DELISTED
Oak Street Health, Inc.
OSH
$1.65B 15.09%
61,384,475
– –
XP icon
4
XP
XP
$8.36B
$1.52B 13.91%
50,537,650
+1,670,000
+3% +$52.1M
ALHC icon
5
Alignment Healthcare
ALHC
$3.81B
$787M 7.19%
70,069,317
– –
SQSP
6
DELISTED
Squarespace, Inc.
SQSP
$573M 5.24%
22,361,073
– –
HRT
7
DELISTED
HireRight Holdings Corporation
HRT
$508M 4.65%
29,719,898
– –
EWCZ
8
DELISTED
European Wax Center
EWCZ
$469M 4.29%
15,882,264
– –
DNA icon
9
Ginkgo Bioworks
DNA
$492M
$366M 3.35%
2,270,270
-518,887
-19% -$101M
ALKT icon
10
Alkami Technology
ALKT
$1.96B
$268M 2.45%
18,729,806
– –
YOU icon
11
Clear Secure
YOU
$5.68B
$250M 2.28%
9,285,013
– –
CNTA
12
DELISTED
Centessa Pharmaceuticals
CNTA
$86.8M 0.79%
9,681,818
– –
HCM icon
13
HUTCHMED
HCM
$1.96B
$75.7M 0.69%
4,000,000
– –
CINC
14
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$72.4M 0.66%
+4,126,470
New +$84.7M
BLND icon
15
Blend Labs
BLND
$436M
$65.2M 0.6%
11,433,949
– –
RPRX icon
16
Royalty Pharma
RPRX
$26.6B
$58.4M 0.53%
1,500,000
– –
OPEN icon
17
Opendoor
OPEN
$3.65B
$54.7M 0.5%
6,532,236
– –
PHVS icon
18
Pharvaris
PHVS
$2.26B
$43.9M 0.4%
2,420,155
– –
BZFD icon
19
BuzzFeed
BZFD
$99.9M
$41.4M 0.38%
1,965,626
– –
LOGC
20
DELISTED
ContextLogic
LOGC
$38M 0.35%
562,949
– –
RSKD icon
21
Riskified
RSKD
$727M
$32.2M 0.29%
5,324,998
– –
IMCR icon
22
Immunocore
IMCR
$1.68B
$28.4M 0.26%
950,000
– –
ARCE
23
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$25M 0.23%
1,183,934
+1,078,896
+1,027% +$21.1M
SONX
24
DELISTED
Sonendo, Inc.
SONX
$13.1M 0.12%
3,267,746
– –
CIH
25
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$10.7M 0.1%
10,122,769
– –
1
2

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

General Atlantic's Q1 2022 Portfolio in Review

As of Q1 2022, General Atlantic held 36 positions worth $10.9B, down 16% from $13B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

General Atlantic's Q1 2022 filing shows 4 new, 5 increased, 1 reduced and 1 closed positions. Its largest new stake was CinCor Pharma, Inc. Common Stock: 4,126,470 shares worth $72.4M. The largest sale was Samsara, an estimated $191M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 47% a quarter earlier, followed by Healthcare and Financials.

  • General Atlantic's largest Q1 2022 buy was CinCor Pharma, Inc. Common Stock: 4,126,470 shares worth $72.4M.
  • General Atlantic added most to XP in Q1 2022, an estimated $52.1M increase.
  • General Atlantic's biggest Q1 2022 reduction was Ginkgo Bioworks, cutting an estimated $101M.
  • General Atlantic fully exited Samsara in Q1 2022, selling an estimated $191M.
  • General Atlantic's ten largest holdings make up 91% of its $10.9B portfolio in Q1 2022.
  • General Atlantic opened 4 new positions and closed 1 in Q1 2022.
  • General Atlantic's portfolio value fell 16% quarter-over-quarter to $10.9B.

Based on General Atlantic's 13F filing for Q1 2022, filed 16 May 2022.